tiletamine hydrochloride has been researched along with Inflammation in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 17 (70.83) | 24.3611 |
| 2020's | 6 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Salhy, M; Keino, H; Kubota, T; Ma, J; Ozaki, M; Sugai, T; Umezawa, K; Zhang, Y | 1 |
| Biavatti, MW; da Rosa, JS; Dalmarco, EM; Lubschinski, TL; Mohr, ETB; Nardino, LA; Pollo, LAE; Sandjo, LP | 1 |
| Hou, H; Li, B; Ying, R; Zhang, Z; Zhu, H | 1 |
| Alharbi, KS; Alotaibi, BS; Alotaibi, MR; Alotaibi, NH; Alotaibi, NM; Alruwaili, NK; Alzarea, AI; Bukhari, SNA | 1 |
| Gerwick, L; Gerwick, WH; Glukhov, E; Lei, XL; Liu, YY; Ma, XX; Nie, YY; Yang, JM; Yang, WC; Zhang, Y | 1 |
| Dacso, CC; Gaber, MW; Kim, JH; Leach, JP; Lonard, DM; Martin, JF; Monroe, TO; Mullany, LK; O'Malley, BW; Ortiz, AR; Rohira, AD; Rosengart, TK; Sarkar, P; Sikora, AG; Song, Y; Stork, B; York, B | 1 |
| Abbasi, SW; Ahmad, S; Ali, G; Jan, MS; Khan Khalil, AA; Khan, J; Khan, R; Rashid, U; Sewell, RE; Ullah, R | 1 |
| Du, F; Fan, S; Guo, W; Homanics, GE; Hou, Y; Liu, D; Lu, J; Pan, T; Xiong, W; Yao, L; Zhang, L; Zou, G | 1 |
| Fukatsu, H; Ichihara, S; Ikegami, A; Izuoka, K; Koide, N; Komatsu, T; Morita, N; Naiki, Y; Tada-Oikawa, S; Ukaji, T; Umezawa, K | 1 |
| Qi, Z; Sun, R; Tian, Z; Wang, X; Wei, H | 1 |
| Botov, S; Hafner, M; Krämer, BK; Ntasis, E; Schmalz, HG; Schmidt, A; Seelen, M; Sollazzo, S; Stamellou, E; Storz, D; van Son, W; Wedel, J; Yard, BA | 1 |
| Hwang, J; Kim, HS; Lee, JH; Lee, TK; Moh, SH; Park, M; Seo, HH; Suh, SS | 1 |
| Chien, CW; Dinkova-Kostova, AT; Higgins, M; Honda, T; Li, W; Mendis, AT; Mierke, DF; Morra, RP; Ojima, I; Zheng, S | 1 |
| Kwon, MJ; Nam, TJ; Ryu, J | 1 |
| Becker, K; Fuchs, D; Ganzera, M; Gostner, JM; Hartmann, A | 1 |
| Dong, C; Hashimoto, K; Honda, T; Ishima, T; Ma, M; Ren, Q; Saito, A; Yang, C; Yao, W; Zhang, JC | 1 |
| Chen, J; Chen, Y; Wang, J; Wang, Q; Wu, P; Wu, Q; Zhang, G; Zhao, J | 1 |
| Cheah, YK; Israf, DA; Kim, MK; Lajis, NH; Lam, KW; Liew, CY; Mohamad, AS; Sulaiman, MR; Tham, CL; Zakaria, ZA | 1 |
| Bevelacqua, Y; Caggia, S; Cardile, V; Coco, M; Frasca, G; Libra, M; Malaponte, G; Mazzarino, MC; Stivala, F; Umezawa, K | 1 |
| Umezawa, K | 2 |
| Li, J; Li, X; Liang, G; Pan, Y; Wang, Y; Yang, S; Ye, F; Yu, C; Zhang, H; Zhang, Y | 1 |
| Akhtar, MN; Akira, A; Israf, DA; Khalid, MH; Khalivulla, SI; Lajis, N; Ming-Tatt, L; Mohamad, AS; Perimal, EK; Sulaiman, MR | 1 |
| Konno, S; Nishimura, M; Ozaki, M; Shimizu, K; Todo, S; Umezawa, K; Yamashita, K | 1 |
3 review(s) available for tiletamine hydrochloride and Inflammation
| Article | Year |
|---|---|
Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ.
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Cyclohexanones; Disease Models, Animal; Humans; Inflammation; Mice; NF-kappa B | 2021 |
Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cyclohexanones; Humans; Inflammation; Molecular Structure; Neoplasms; NF-kappa B; Peritoneum | 2011 |
[Screening of bioactive metabolites that suppress inflammation].
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Biological Products; Cell Differentiation; Cyclohexanones; Depsipeptides; Drug Design; Drug Evaluation, Preclinical; Inflammation; Inflammation Mediators; Lipopolysaccharides; Neoplasms; NF-kappa B; Osteoclasts; Piperidones; Signal Transduction | 2007 |
21 other study(ies) available for tiletamine hydrochloride and Inflammation
| Article | Year |
|---|---|
Effect of Aryl-Cyclohexanones and their Derivatives on Macrophage Polarization In Vitro.
Topics: Anti-Inflammatory Agents; Cyclohexanones; Cytokines; Humans; Inflammation; Macrophages | 2022 |
The Protective Effect of Mycosporine-Like Amino Acids (MAAs) from
Topics: Amino Acids; Animals; Antioxidants; Cyclohexanones; Cyclohexylamines; Cytokines; Glycine; Inflammation; Male; Mice; Mice, Inbred ICR; Protective Agents; RNA, Messenger; Skin; Skin Diseases; Ultraviolet Rays | 2019 |
Pharmacological appraisal of ligustrazine based cyclohexanone analogs as inhibitors of inflammatory markers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclohexanones; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Inflammation; Lipoxygenase Inhibitors; Pyrazines; Structure-Activity Relationship | 2020 |
An anti-inflammatory isoflavone from soybean inoculated with a marine fungus
Topics: 4-Butyrolactone; Acetylcholinesterase; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Aspergillus; Cholinesterase Inhibitors; Cyclohexanones; Free Radical Scavengers; Furocoumarins; Genistein; Glycine max; Inflammation; Isoflavones; Lipopolysaccharides; Mice; RAW 264.7 Cells | 2020 |
A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction.
Topics: Animals; Cell Differentiation; Cyclohexanones; Fibroblasts; Fibrosis; Heart Function Tests; Inflammation; Macrophages; Mice; Myocardial Infarction; Pyridines; RAW 264.7 Cells; Receptors, Steroid; RNA; Transcription, Genetic; Ventricular Remodeling | 2020 |
Mechanistic evaluation of a novel cyclohexenone derivative's functionality against nociception and inflammation: An in-vitro, in-vivo and in-silico approach.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Behavior, Animal; Computer Simulation; Cyclohexanones; Cyclohexenes; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Edema; Female; Inflammation; Lipoxygenase Inhibitors; Male; Mice, Inbred BALB C; Nociceptive Pain; Receptors, GABA; Receptors, Opioid | 2021 |
Involvement of glycine receptor α1 subunits in cannabinoid-induced analgesia.
Topics: Action Potentials; Analgesics; Animals; Animals, Genetically Modified; Cannabinoids; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Gene Expression Regulation; Glycine Agents; HEK293 Cells; Humans; In Vitro Techniques; Inflammation; Male; Mice; Mice, Inbred C57BL; Mutation; Neurons; Pain; Pain Measurement; Patch-Clamp Techniques; Receptors, Glycine; Reflex, Startle; Rotarod Performance Test; Spinal Cord; Strychnine; Time Factors; Transfection | 2018 |
NF‑κB inhibitor DHMEQ inhibits titanium dioxide nanoparticle‑induced interleukin‑1β production: Inhibition of the PM2.5‑induced inflammation model.
Topics: Animals; Benzamides; Biomarkers; Caspase 1; Caspase Inhibitors; Cell Line; Cyclohexanones; Disease Models, Animal; Humans; Inflammation; Interleukin-1beta; Macrophages; Models, Molecular; Nanoparticles; NF-kappa B; Particulate Matter; Potassium; Titanium | 2018 |
Infiltrating neutrophils aggravate metabolic liver failure in fah-deficient mice.
Topics: Animals; Bilirubin; Body Weight; Cyclohexanones; Disease Models, Animal; Hepatocytes; Hydrolases; Inflammation; Interleukin-22; Interleukins; Liver; Liver Failure; Male; Mice; Mice, Knockout; Neutrophils; Nitrobenzoates; Receptors, CCR2; Tyrosine | 2015 |
Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation.
Topics: Apoptosis; Carbon Monoxide; Coordination Complexes; Cyclohexanones; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Iron Compounds; NF-E2-Related Factor 2; NF-kappa B; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2014 |
Anti-inflammation activities of mycosporine-like amino acids (MAAs) in response to UV radiation suggest potential anti-skin aging activity.
Topics: Amino Acids; Anti-Inflammatory Agents; Cell Line; Chlamydomonas; Chlorophyta; Cyclohexanols; Cyclohexanones; Cyclohexylamines; Cyclooxygenase 2; Elastin; Extracellular Matrix Proteins; Fibroblasts; Glycine; Glycoproteins; Humans; Inflammation; Skin; Skin Aging; Ultraviolet Rays | 2014 |
New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase.
Topics: Adaptor Proteins, Signal Transducing; Alkynes; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carboxylic Ester Hydrolases; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Cyclohexanones; Cytoskeletal Proteins; Inflammation; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Liver Neoplasms; Macrophages; Mice; Models, Molecular; Molecular Structure; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Signal Transduction; Structure-Activity Relationship | 2015 |
Nrf2 and NF-κB Signaling Pathways Contribute to Porphyra-334-Mediated Inhibition of UVA-Induced Inflammation in Skin Fibroblasts.
Topics: Antioxidants; Cells, Cultured; Cyclohexanones; Fibroblasts; Glycine; Humans; Inflammation; Interleukin-6; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Skin; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 2015 |
Immunomodulatory Effects of the Mycosporine-Like Amino Acids Shinorine and Porphyra-334.
Topics: Amino Acids; Cell Line, Tumor; Cyclohexanones; Cyclohexylamines; Glycine; Humans; Immunologic Factors; Inflammation; NF-kappa B; Porphyra; Rhodophyta; Tryptophan | 2016 |
Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanones; Depression; Disease Models, Animal; Inflammation; Male; Nerve Growth Factor; Neuronal Outgrowth; NF-E2-Related Factor 2; PC12 Cells; Phenanthrenes; Rats; Tumor Necrosis Factor-alpha | 2016 |
Ketamine Analog Methoxetamine Induced Inflammation and Dysfunction of Bladder in Rats.
Topics: Animals; Body Weight; Cell Line; Chemokines; Cyclohexanones; Cyclohexylamines; Epithelial Cells; Epithelium; Extracellular Matrix; Female; Gene Expression Regulation; Inflammation; Inflammation Mediators; Ketamine; Macrophages; Mast Cells; Mucous Membrane; Rats; Rats, Sprague-Dawley; Up-Regulation; Urinary Bladder; Urination; Urodynamics | 2017 |
A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis.
Topics: Animals; Cell Line; Cell Survival; Chemokines; Curcumin; Cyclohexanones; Cytokines; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Mice; Nitric Oxide; Nitric Oxide Synthase Type II | 2010 |
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Line; Chemokine CCL2; Chemokine CCL5; Cyclohexanones; Histamine; Humans; Hydrocortisone; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-8; Keratinocytes; NF-kappa B | 2010 |
A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo.
Topics: Acute Disease; Animals; Benzylidene Compounds; Cyclohexanones; Cytokines; Disease Models, Animal; Edema; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Inflammation; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Lung; Macrophages, Peritoneal; Male; Mice; NF-kappa B; Nitric Oxide; Phosphorylation; RNA, Messenger; Survival Analysis | 2011 |
Antinociceptive activity of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxy-3-methoxybenzylidene)cyclohexanone, on nociception-induced models in mice.
Topics: Analgesics; Animals; Curcumin; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Inflammation Mediators; Inhibitory Concentration 50; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Pain; Toxicity Tests, Acute | 2012 |
Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.
Topics: Airway Remodeling; Animals; Asthma; Benzamides; Bronchoalveolar Lavage Fluid; Cells, Cultured; Cyclohexanones; Cytokines; Disease Models, Animal; Eosinophils; Epithelial Cells; Female; Humans; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; NF-kappa B; Respiratory Hypersensitivity | 2012 |